用户名: 密   码:
注册 | 忘记密码?
专利详细信息
专利号
CN102846546B
专利标题 Can promote propranolol composite phospholipid carrier that percutaneous absorbs and preparation method thereof and application
专利权人 Nanjing University Of Chinese Medicine;
发明人
申请号 CN20121130344
申请日 2012/4/27
公开日 2014/3/19
优先权号
IPC A61K00912700;
专利类型
法律状态查询 查看法律状态


The invention provides a kind of composite phospholipid carrier that can promote the absorption of Propranolol percutaneous and preparation method thereof it is by the phospholipid material of two kinds of different phase transition temperatures---dipalmitoyl phosphatidyl choline and soybean phospholipid as composite phospholipid material the Propranolol composite phospholipid carrier that thus prepared by phospholipid material with in prior art only adopt the carrier of single phospholipid material and compare envelop rate is significantly improved leak and reduce stability in rat plasma improves and percutaneous dosing artifact availability also significantly improves.By Propranolol composite phospholipid carrier provided by the invention be particularly useful for treating infant hemangioma can realize Propranolol transdermal administration and act directly on hemangioma affected part when improving curative effect reducing toxic and side effects improve the compliance of infant medication.The present invention simultaneously also provides the preparation method of this kind of Propranolol composite phospholipid carrier.
没有相关的数据
没有相关的数据
引证图片
暂无附图

注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。

上传 | 编辑 | 标注(0) | 下载专利全文 | 收藏